Literature DB >> 2041238

Serum CEA levels in patients with gastric carcinoma correlate with the tumorigenicity of their xenografts in nude mice.

T Kiyama1, M Onda, A Tokunaga, T Okuda, T Mizutani, T Yoshiyuki, Y Shimizu, K Nishi, N Matsukura, N Tanaka.   

Abstract

We examined the correlation among preoperative serum carcinoembryonic antigen (CEA) levels, staining properties of the tumors by CEA immunohistochemistry and the tumorigenicity of their xenografts in nude mice, in 28 patients with gastric cancer. Eleven (40 per cent) of them were positive for serum CEA (greater than or equal to 2.5 ng/ml) and seven (25 per cent) of the xenografts were tumorigenic in nude mice. All the tumorigenic cases were positive for serum CEA (p less than 0.001) and the mean value of the serum CEA level in the patients with tumorigenic neoplasms was 20.8 ng/ml, being significantly higher than that (1.4 ng/ml) in the patients with non-tumorigenic neoplasms (p less than 0.001). Twenty-five of the 28 carcinomas (89 per cent) were positive for CEA staining in their cancer cells by the ABC method and CEA localization correlated with tumorigenicity (p less than 0.05). These results suggest that the serum CEA level in patients is correlated with the tumorigenicity of their gastric carcinoma xenografts in nude mice and may account for the poor prognosis of patients with high serum CEA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041238     DOI: 10.1007/bf02470863

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  18 in total

1.  Heterotransplantation of a human malignant tumour to "Nude" mice.

Authors:  J Rygaard; C O Povlsen
Journal:  Acta Pathol Microbiol Scand       Date:  1969

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Immunohistochemical demonstration of epidermal growth factor in human gastric cancer xenografts of nude mice.

Authors:  T Yoshiyuki; Y Shimizu; M Onda; A Tokunaga; T Kiyama; K Nishi; T Mizutani; N Matsukura; N Tanaka; M Akimoto
Journal:  Cancer       Date:  1990-02-15       Impact factor: 6.860

4.  A new direct solid-phase radioimmunoassay for carcinoembryonic antigen without pretreatment of serum samples.

Authors:  Y Matsuoka; M Kuroki; Y Koga; H Ogawa; N Nakazawa; S Tachibana; T Minamizawa
Journal:  J Immunol Methods       Date:  1983-03-11       Impact factor: 2.303

5.  Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.

Authors:  H J Wanebo; B Rao; C M Pinsky; R G Hoffman; M Stearns; M K Schwartz; H F Oettgen
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

6.  Correlation between carcinoembryonic antigen in gastric cancer tissue and survival of patients with gastric cancer.

Authors:  O Kojima; E Ikeda; Y Uehara; T Majima; Y Fujita; S Majima
Journal:  Gan       Date:  1984-03

7.  The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.

Authors:  R Goslin; G Steele; J Macintyre; R Mayer; P Sugarbaker; K Cleghorn; R Wilson; N Zamcheck
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

8.  The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.

Authors:  C G Moertel; J R O'Fallon; V L Go; M J O'Connell; G S Thynne
Journal:  Cancer       Date:  1986-08-01       Impact factor: 6.860

9.  Estrogen and progesterone receptors in gastric cancer.

Authors:  A Tokunaga; K Nishi; N Matsukura; N Tanaka; M Onda; A Shirota; G Asano; K Hayashi
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

10.  Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Correlation with plasma carcinoembryonic antigen levels.

Authors:  Y Hamada; M Yamamura; K Hioki; M Yamamoto; H Nagura; K Watanabe
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.